This is a distressed financing package. The floating-rate conversion feature means any stock price decline accelerates dilution. Monitor for stockholder approval requests and further tranche exercises under the Leviston IRA. The $3.6M additional investment right is a massive overhang. Expect continued dilution and potential Nasdaq compliance issues given the 19.99% exchange cap. Short-term traders should watch for price weakness on conversion notices.
Price Chart
Executive Summary
Mobix Labs issued a $1.2M senior secured convertible note (net proceeds $1M) to Leviston Resources and sold $1,000 of Series A convertible preferred stock with a warrant to Kips Bay Select, alongside issuing 834,782 common shares as an extension fee. The Class B-to-Class A conversion eliminated supervoting rights and triggered the automatic departure and immediate reappointment of three Class B directors. The combination of dilutive financing, a short-term 10% note maturing December 2026, and a new $3.6M investment right for Leviston signals severe cash constraints and a reliance on toxic convertible funding, which is bearish for common equity holders.
Key Financial Metrics
Key Facts
- Issued $1.2M senior secured convertible note to Leviston Resources for $1M net cash (16.667% OID), bearing 10% interest, maturing December 28, 2026.
- Conversion price is the lower of the August 28 closing price or 85% of the lowest 8-day VWAP — a floating-rate structure that maximizes dilution to common shareholders.
- Issued 1,000 shares of Series A 10% Convertible Preferred Stock to Kips Bay Select for $1,000, plus a warrant to purchase up to 6,000 additional preferred shares at $1,000 each.
- Issued 834,782 shares of Class A common stock to Kips Bay Select as an extension fee for amending their purchase agreement.
- All outstanding Class B common stock was converted to Class A common stock, eliminating 10:1 supervoting rights and reducing the board from 8 to 5 directors, then immediately back to 8 with the same individuals reappointed.
- The Leviston Investor Rights Agreement grants a right to purchase up to $3.6M in additional notes (net $3M cash) over the next 7 months, with a $300K minimum tranche.
- Conversion of the note and preferred shares is conditioned on stockholder approval, with a 19.99% exchange cap under Nasdaq rules.
Financial Impact
Immediate net cash inflow of ~$1M from Leviston and $1,000 from Kips, but at the cost of up to $4.8M in potential convertible debt/preferred dilution. The 834,782 extension shares alone represent ~4.4% dilution on a $19M market cap. The floating conversion price ensures maximum dilution to common.
Risk Factors
- Massive dilution from convertible note and preferred stock conversions at floating prices.
- Short-term maturity (Dec 2026) on the Leviston note creates refinancing risk.
- Nasdaq 19.99% exchange cap limits conversion, requiring stockholder approval that may not pass.
- The $3.6M Leviston IRA is a toxic financing facility that can be drawn down in $300K tranches, creating persistent dilution.
- Class B conversion eliminates insider control, potentially reducing governance stability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040658 |
| Document: 0001493152-26-040658-index.html | 0001493152-26-040658 |
| Document: 0001493152-26-040658.txt | 0001493152-26-040658 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.7320 | awaiting T+20 | — | $0.7590 (+3.69%) |
Oct 16, 2026 10d ago | DEFA14A | $0.7450 | awaiting T+20 | — | $0.7590 (+1.88%) |
Oct 16, 2026 10d ago | 8-K | $0.7450 | awaiting T+20 | — | $0.7590 (+1.88%) |
Oct 9, 2026 17d ago | DEFA14A | $0.7800 | awaiting T+20 | — | $0.7590 (−2.69%) |
Oct 9, 2026 17d ago | 8-K | $0.7800 | awaiting T+20 | — | $0.7590 (−2.69%) |
Oct 8, 2026 18d ago | 144 | $1.13 | awaiting T+20 | — | $0.7590 (−32.83%) |
Sep 4, 2026 7w ago | EFFECT | $0.9301 $0.6501 | ▲ +30.10% | ▲ +30.71% | $0.7590 (+18.40%) |
Aug 28, 2026 8w ago | S-1 | $1.32 $0.8419 | ▲ +36.22% | ▲ +36.03% | $0.7590 (+42.50%) |
Aug 28, 2026 8w ago | 8-K | $1.32 $0.8419 | ▲ +36.22% | ▲ +36.03% | $0.7590 (+42.50%) |
Jul 17, 2026 14w ago | EFFECT | $1.97 $1.27 | ▲ +35.53% | ▲ +39.98% | $0.7590 (+61.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers